An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

@inproceedings{Patel2014AnEM,
  title={An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany},
  author={Dipen A. Patel and Andre Michel and Jennifer M L Stephens and Bertram Weber and Christian Petrik and Claudie Charbonneau},
  booktitle={Infection and drug resistance},
  year={2014}
}
BACKGROUND Across Europe, methicillin-resistant Staphylococcus aureus (MRSA) is considered to be the primary cause of nosocomial pneumonia (NP). In Germany alone, approximately 14,000 cases of MRSA-associated NP occur annually, which may have a significant impact on health care resource use and associated economic costs. The objective of this study was to… CONTINUE READING